As of 2025-04-22, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is 159.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 455.61 mil USD. MRVI's TTM EBITDA according to its financial statements is 2.85 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 20.8x | 17.6x |
| Forward P/E multiples | 23.7x - 27.2x | 26.1x |
| Fair Price | 0.14 - 0.28 | 0.22 |
| Upside | -92.1% - -84.0% | -87.4% |
| Date | EV/EBITDA |
| 2025-04-21 | 155.68 |
| 2025-04-17 | 159.70 |
| 2025-04-16 | 155.24 |
| 2025-04-15 | 156.13 |
| 2025-04-14 | 159.70 |
| 2025-04-11 | 165.04 |
| 2025-04-10 | 160.59 |
| 2025-04-09 | 174.85 |
| 2025-04-08 | 169.50 |
| 2025-04-07 | 179.31 |
| 2025-04-04 | 174.85 |
| 2025-04-03 | 189.11 |
| 2025-04-02 | 198.92 |
| 2025-04-01 | 194.46 |
| 2025-03-31 | 198.92 |
| 2025-03-28 | 212.29 |
| 2025-03-27 | 211.40 |
| 2025-03-26 | 213.18 |
| 2025-03-25 | 206.94 |
| 2025-03-24 | 201.60 |
| 2025-03-21 | 203.82 |
| 2025-03-20 | 215.86 |
| 2025-03-19 | 218.53 |
| 2025-03-18 | 231.91 |
| 2025-03-17 | 237.26 |
| 2025-03-14 | 220.32 |
| 2025-03-13 | 217.64 |
| 2025-03-12 | 234.58 |
| 2025-03-11 | 237.26 |
| 2025-03-10 | 256.87 |
| 2025-03-07 | 265.78 |
| 2025-03-06 | 239.93 |
| 2025-03-05 | 252.41 |
| 2025-03-04 | 255.08 |
| 2025-03-03 | 271.13 |
| 2025-02-28 | 288.96 |
| 2025-02-27 | 273.81 |
| 2025-02-26 | 291.64 |
| 2025-02-25 | 281.83 |
| 2025-02-24 | 359.39 |
| 2025-02-21 | 368.30 |
| 2025-02-20 | 354.04 |
| 2025-02-19 | 365.63 |
| 2025-02-18 | 367.41 |
| 2025-02-14 | 376.33 |
| 2025-02-13 | 369.19 |
| 2025-02-12 | 381.68 |
| 2025-02-11 | 379.89 |
| 2025-02-10 | 385.24 |
| 2025-02-07 | 410.20 |